Kukui nut oil (Aleurites moluccanus seed oil) promotes hair growth by activating the Nrf2/ARE-AKR1C family-PGF2α signaling axis.
Summary
Ex vivo human hair follicle assays showed that kukui nut (AMS) oil increases hair growth while elevating PGF2α and AKR1C expression and upregulating proliferation markers. Transcriptomics linked these effects to Nrf2/ARE activation, and a randomized, double-blind left-right human test confirmed enhanced eyelash growth.
Key Findings
- AMS oil promoted hair growth in ex vivo human hair follicle culture.
- PGF2α levels increased alongside upregulation of AKR1C family enzymes crucial for PGF2α synthesis.
- Proliferation markers Ki67 and cyclins B1/D1/E1 were upregulated.
- Transcriptomic analyses showed Nrf2 activation and ARE-mediated regulation of AKR1C genes.
- A randomized, double-blind, left-right human test confirmed enhanced eyelash growth.
Clinical Implications
Supports development of topical formulations targeting the Nrf2/AKR1C–PGF2α pathway for hair and eyelash growth. Safety profiling, dose–response, durability, and comparison with prostaglandin analogs are needed before broad clinical or consumer use.
Why It Matters
This study identifies a mechanistic Nrf2/ARE–AKR1C–PGF2α axis for plant oil-driven hair growth and provides randomized human evidence for eyelash efficacy, bridging mechanistic discovery to cosmeceutical application.
Limitations
- Human sample size, follow-up duration, and detailed clinical endpoints are not specified in the abstract.
- Generalizability to scalp hair growth and diverse populations remains untested.
Future Directions
Define dose–response and duration of effect; conduct larger, CONSORT-compliant RCTs versus prostaglandin analogs; assess long-term safety and mechanistic specificity of Nrf2/AKR1C targeting.
Study Information
- Study Type
- RCT
- Research Domain
- Treatment
- Evidence Level
- II - Small randomized, double-blind, within-subject human test with strong mechanistic support; not a large definitive RCT.
- Study Design
- OTHER